Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Detailed price information for Disc Medicine Inc (IRON-Q) from The Globe and Mail including charting and trades.

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPPP ...

Join Drs Tania Jain and Prithviraj Bose as they discuss the available JAK inhibitors and how they use them to treat ...

Spanish brake component manufacturers, and wavy disc pioneers, Galfer are proof of this and have today (May 7) unveiled an all-new disc design called Floatech – the core concept of which remains ...

Plan to initiate Phase 2 study of DISC-3405 in polycythemia vera (PV) in H1 2025 Expect data readouts for DISC-0974 program in H2 2025, including initial results of Phase 2 anemia of myelofibrosis (MF ...

Reports have emerged that the next major Microsoft published game on PS5 won’t have the full game on disc, leaving players concerned. Following its acquisition, Bethesda has been putting game ...

This article will centralize on discussing the top-rated heme iron supplements available in the market. Heme iron is a type of iron that is found in animal-based foods, such as meat, poultry ...

Update [Sat 10th May 2025, 9:15am]: As was the case with Indiana Jones and the Great Circle earlier in the year, Microsoft and Bethesda have short changed PS5 fans yet again by shipping physical ...

The FDA has approved the first and only self-collection cervical cancer screening device, where patients can obtain their own samples from the comfort of their own home. An evaluation of nearly ...

Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA. Shares in the company gained almost ...

Please provide your email address to receive an email when new articles are posted on . There is a dearth of high-level evidence by which to assign gradings. American Society of Transplantation ...